概览
March 10-12: Forum
Due to unforeseen circumstances, DIA needs to shift the dates and location of the 2025 Medical Affairs and Scientific Communications Forum from March 3-5 to March 10-12, 2025. We hope you join us at The Westin Boston Seaport District for this signature event!
DIA’s Medical Affairs and Scientific Communications Forum embodies our commitment to fostering innovation and enhancing global health and well-being. Tailored specifically for medical affairs professionals, by medical affairs professionals, this forum serves as a dynamic platform for exchanging vital insights and tackling current challenges and trends on the top of everyone’s mind.
With a focus on cultivating interdepartmental relationships, this forum offers a unique opportunity for professionals across diverse job types within the medical affairs domain to collaborate and synergize. Featuring multiple general and breakout sessions organized into three tracks—medical communications, medical writing, and field medical—the forum enables attendees to delve into topics most relevant to their roles and interests. By participating in this multidisciplinary gathering, attendees gain a comprehensive understanding of the regulatory and compliance landscape that directly impacts their daily responsibilities.
Participant Testimonials
The DIA MASC was a new conference for me - and it was very exciting and inspiring to connect with many colleagues across industry who work in different parts of drug development than I typically do. That exchange of ideas, solutions and possibilities was very inspiring! – Jane Myles, Decentralized Trials and Research Alliance (DTRA)
I loved the size of the event! It made it easy to connect and have meaningful conversations. Everyone was approachable and eager to engage and answer questions, which allowed the discussions to continue beyond the sessions. – Leanne Woehlke, Transperfect
By sharing insights and exploring cutting-edge issues together, we not only address current challenges but also anticipat future legal landscapes, preparing ourselves for the evolution of medical affairs and scientific communication. The opportunity to collaborate with experts from diverse backgrounds adds significant value to my work, broadening my perspective and deepening my understanding of the multifaceted issues our clients face. This experience has been incredibly rewarding, and I am eagerly looking forward to contributing to and learning from this vibrant community at future events. The DIA MASC Forum is a cornerstone for professional development and networking in our field, and I am grateful for the chance to be a part of it. – Darshan Kulkarni, The Kulkarni Law Firm
Keynote Address!
March 10 | 1:30-2:15PM
Jessica Steier, DrPH, PMP, Founder and Host, Unbiased Science
Featured
Want to learn more about Medical Affairs and Scientific Communications Forum? You've come to the right site!
项目委员会
-
Marie-Ange Noue, PhD Senior Director, Head of Scientific Communications
EMD Serono, Canada -
Elizabeth Brown, MS, PMP Executive Director, Medical Writing & Disclosure
Merck & Co., Inc., United States -
Elizabeth Froom, PharmD, RPh Senior Director, Medical Writing and Healthcare Communications
Evidera, United States -
Darshan Kulkarni, JD, PharmD, MS Principal Attorney
The Kulkarni Law Firm, United States -
Christina Nixon, PhD Senior Director, Medical and Scientific Communications
Alphanumeric, United States -
Yvonne Mehta, PharmD Director, Global Medical Information
Gilead Sciences, Inc, United States -
Brooke Elizabeth Hollands, PharmD Head Medical Affairs Strategy and Operations
GlaxoSmithKline, United States -
Elizabeth Olbrich, MS, RN Associate Director
Evidera | PPD, United States -
Nimita Limaye, PhD Research Vice President, Life Sciences R&D Strategy and Technology
IDC, United States -
Sudipta Chakraborty, PhD Clinical Trial Transparency Strategy Lead
Biogen, United States -
Fabiana Ebihara Director, Medical Writing Services
Parexel International, United States -
Richard Swank, PhD Founder
Scientific Engagement LLC, United States -
Iris Tam, PharmD Senior Vice President and Head, Medical Affairs and HEOR
COEUS, United States -
Sarah Jarvis, MBA Global Medical Affairs Lead
ZS, United States -
J. Lynn Bass, PharmD, RPh Senior Director, Medical Science Liaisons
BridgeBio, United States -
Craig Klinger, RPh Director - Global MSL Trainer, The Office of Medical Professional Development
Eli Lilly and Company, United States -
Jim Wilkinson, PhD U.S. Medical Affairs Lead, Medical Affairs & Evidence Generation
Argenx, United States -
Representative Invited DIA, United States